Charles Schwab’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-61,985
| Closed | -$144K | – | 3182 |
|
|
2018
Q2 | $144K | Buy |
61,985
+3,612
| +6% | +$8.39K | ﹤0.01% | 3089 |
|
|
2018
Q1 | $186K | Buy |
58,373
+3,276
| +6% | +$10.4K | ﹤0.01% | 3001 |
|
|
2017
Q4 | $226K | Buy |
55,097
+4,368
| +9% | +$17.9K | ﹤0.01% | 2957 |
|
|
2017
Q3 | $230K | Buy |
50,729
+4,717
| +10% | +$21.4K | ﹤0.01% | 2972 |
|
|
2017
Q2 | $154K | Sell |
46,012
-35,987
| -44% | -$120K | ﹤0.01% | 3063 |
|
|
2017
Q1 | $756K | Buy |
81,999
+4,617
| +6% | +$42.6K | ﹤0.01% | 2515 |
|
|
2016
Q4 | $597K | Buy |
77,382
+4,158
| +6% | +$32.1K | ﹤0.01% | 2595 |
|
|
2016
Q3 | $837K | Buy |
73,224
+30,403
| +71% | +$348K | ﹤0.01% | 2450 |
|
|
2016
Q2 | $528K | Buy |
42,821
+588
| +1% | +$7.25K | ﹤0.01% | 2567 |
|
|
2016
Q1 | $427K | Buy |
42,233
+714
| +2% | +$7.22K | ﹤0.01% | 2638 |
|
|
2015
Q4 | $936K | Buy |
41,519
+910
| +2% | +$20.5K | ﹤0.01% | 2417 |
|
|
2015
Q3 | $674K | Buy |
40,609
+2,465
| +6% | +$40.9K | ﹤0.01% | 2515 |
|
|
2015
Q2 | $859K | Buy |
38,144
+7,066
| +23% | +$159K | ﹤0.01% | 2487 |
|
|
2015
Q1 | $802K | Buy |
31,078
+1,508
| +5% | +$38.9K | ﹤0.01% | 2458 |
|
|
2014
Q4 | $644K | Buy |
29,570
+793
| +3% | +$17.3K | ﹤0.01% | 2535 |
|
|
2014
Q3 | $545K | Buy |
28,777
+6,012
| +26% | +$114K | ﹤0.01% | 2553 |
|
|
2014
Q2 | $531K | Buy |
22,765
+10,220
| +81% | +$238K | ﹤0.01% | 2600 |
|
|
2014
Q1 | $423K | Buy |
12,545
+300
| +2% | +$10.1K | ﹤0.01% | 2657 |
|
|
2013
Q4 | $362K | Buy |
12,245
+360
| +3% | +$10.6K | ﹤0.01% | 2710 |
|
|
2013
Q3 | $188K | Buy |
+11,885
| New | +$188K | ﹤0.01% | 2941 |
|